Dabigatran

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Dabigatran and local guidelines before prescribing.

Direct thrombin inhibitor (DOAC)

Mechanism

Direct thrombin inhibitor (prodrug dabigatran etexilate).

Uses

Stroke prevention in non-valvular AF, treatment and prevention of VTE.

Dosing

2 more dose entries from the chapters

Side effects

Dyspepsia, bleeding, GI bleeding; rarely hepatic injury.

Interactions

P-gp inhibitors (dronedarone, ketoconazole) and inducers (rifampicin) alter levels; avoid other anticoagulants.

Contraindications and cautions

Active bleeding, mechanical valve, CrCl below 30, strong P-gp inhibitors

Monitoring

Renal function, Hb

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Avoid if CrCl below 30; renally cleared

Overdose and reversal

Idarucizumab

Special advice

Idarucizumab reverses; avoid in severe renal impairment; capsules must be swallowed whole in original packaging.

More from the textbook: uses, cautions and other points
Where it is discussed in the book